WP Advisors’s GSK GSK Stock Holding History

WP Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-342	Closed	-$17K	–	132
2018 Q3	$17K	Hold	342	–	–	0.02%	190
2018 Q2	$17K	Buy	+342	New	+$17.2K	0.02%	201

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

WP Advisors's GSK Position: Q4 2018 in Review

WP Advisors sold out of GSK (GSK) in Q4 2018, closing a stake of 342 shares — an estimated $17K sold.

WP Advisors first reported a position in GSK in Q2 2018 and held it in 2 quarters. The position peaked at $17K in Q3 2018. 799 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

WP Advisors reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
WP Advisors sold 342 GSK shares in Q4 2018, an estimated $17K.
WP Advisors first reported a position in GSK in Q2 2018 and held it in 2 quarters.
WP Advisors's GSK position peaked at $17K in Q3 2018.
799 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on WP Advisors's 13F filing for Q4 2018, filed 18 Jan 2019.